146 related articles for article (PubMed ID: 33107671)
21. Polysaccharides from aloe vera target the Wnt/β-catenin pathway to impact the tooth density of pulpitis rats.
Jiang L; Lu Y; Zhao H; He W
Acta Cir Bras; 2023; 37(12):e371202. PubMed ID: 36651427
[TBL] [Abstract][Full Text] [Related]
22. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
23. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.
Park KH; Kang JW; Lee EM; Kim JS; Rhee YH; Kim M; Jeong SJ; Park YG; Kim SH
J Pineal Res; 2011 Sep; 51(2):187-94. PubMed ID: 21470302
[TBL] [Abstract][Full Text] [Related]
24. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
[TBL] [Abstract][Full Text] [Related]
26. CCN3 protein participates in bone regeneration as an inhibitory factor.
Matsushita Y; Sakamoto K; Tamamura Y; Shibata Y; Minamizato T; Kihara T; Ito M; Katsube K; Hiraoka S; Koseki H; Harada K; Yamaguchi A
J Biol Chem; 2013 Jul; 288(27):19973-85. PubMed ID: 23653360
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
28. Effect of TAK1 on osteogenic differentiation of mesenchymal stem cells by regulating BMP-2 via Wnt/β-catenin and MAPK pathway.
Yang H; Guo Y; Wang D; Yang X; Ha C
Organogenesis; 2018 Jan; 14(1):36-45. PubMed ID: 29913119
[TBL] [Abstract][Full Text] [Related]
29. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
30. Electromagnetic field treatment increases purinergic receptor P2X7 expression and activates its downstream Akt/GSK3β/β-catenin axis in mesenchymal stem cells under osteogenic induction.
Zhang Y; Li W; Liu C; Yan J; Yuan X; Wang W; Wang H; Wu H; Yang Y
Stem Cell Res Ther; 2019 Dec; 10(1):407. PubMed ID: 31864409
[TBL] [Abstract][Full Text] [Related]
31. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
[TBL] [Abstract][Full Text] [Related]
32. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
[TBL] [Abstract][Full Text] [Related]
33. The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells.
AlShaibi HF; Ahmed F; Buckle C; Fowles ACM; Awlia J; Cecchini MG; Eaton CL
Biotechnol Appl Biochem; 2018 May; 65(3):407-418. PubMed ID: 28981962
[TBL] [Abstract][Full Text] [Related]
34. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
[TBL] [Abstract][Full Text] [Related]
35. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
36. 6-Bromoindirubin-3'-oxime promotes osteogenic differentiation of canine BMSCs through inhibition of GSK3β activity and activation of the Wnt/β-catenin signaling pathway.
Zhao XE; Yang Z; Gao Z; Ge J; Wei Q; Ma B
An Acad Bras Cienc; 2019 Mar; 91(1):e20180459. PubMed ID: 30916158
[TBL] [Abstract][Full Text] [Related]
37. Silencing GSK3β instead of DKK1 can inhibit osteogenic differentiation caused by co-exposure to fluoride and arsenic.
Zeng Q; Xu Y; Yu X; Yang J; Hong F; Zhang A
Bone; 2019 Jun; 123():196-203. PubMed ID: 30890376
[TBL] [Abstract][Full Text] [Related]
38. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism.
Fukuda T; Kokabu S; Ohte S; Sasanuma H; Kanomata K; Yoneyama K; Kato H; Akita M; Oda H; Katagiri T
Differentiation; 2010 Jul; 80(1):46-52. PubMed ID: 20546990
[TBL] [Abstract][Full Text] [Related]
39. Corylin, a flavonoid derived from Psoralea Fructus, induces osteoblastic differentiation via estrogen and Wnt/β-catenin signaling pathways.
Yu AX; Xu ML; Yao P; Kwan KK; Liu YX; Duan R; Dong TT; Ko RK; Tsim KW
FASEB J; 2020 Mar; 34(3):4311-4328. PubMed ID: 31965654
[TBL] [Abstract][Full Text] [Related]
40. Morinda citrifolia Leaf Extract Enhances Osteogenic Differentiation Through Activation of Wnt/β-Catenin Signaling.
Gu H; Boonanantanasarn K; Kang M; Kim I; Woo KM; Ryoo HM; Baek JH
J Med Food; 2018 Jan; 21(1):57-69. PubMed ID: 28981378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
